Survival outcomes, hematologic complications and growth impairment after sequential chemoradiotherapy in intracranial NGGCTs: a retrospective study
ConclusionOur study suggested that a combined treatment modality with at least four cycles of chemotherapy and CSI was safe and effective for patients with intracranial NGGCTs. Radiotherapy should be used with caution for patients< 11.5 years due to growth impairment.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Chemotherapy | Child Development | Germ Cell Tumors | Hematology | Hormones | Study | Thrombocytopenia | Toxicology